#BIIS18 Interview: OrbiMed Asia's Jonathan Wang on his upbringing, deciding against a consulting career, blunt advice for Chinese entrepreneurs, and more
Next week we kick off the first annual US-China Biopharma Innovation and Investment Summit in Shanghai, featuring some of the leading transpacific newsmakers in biopharma who are blazing new paths forward in global drug development. The game has changed in China and today we’re bringing you an interview with one of the main players, Jonathan Wang, the founding partner of OrbiMed Asia and #BIIS18 featured speaker.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.